Seawolf Therapeutics
Biotech · Private
Immunology therapeutics targeting autoimmune and inflammatory diseases
seawolftx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 18
- 0 granted · 18 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1647 | GENERAL NUTRACEUTICAL TECHNOLOGY LLC | — | — |
| 1648 | Boston Immune Technologies And Therapeutics Inc. | — | — |
| 1649 | Respana Therapeutics, Inc | — | — |
| 1650 | Seawolf Therapeutics | — | — |
| 1651 | KARIS BIO USA, INC. | — | — |
| 1652 | Eureka Therapeutics, Inc. | — | $86M |
| 1653 | ALPH TECHNOLOGIES LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Unsaturated Ionizable Lipids And Nanoparticle Compositions Thereofapplication
- Nuclear Targeted DNA Delivery and Compositions for Use in Practicing the Sameapplication
- Enhanced Nuclear Delivery Of Dna And Compositions For Use In Practicing The Sameapplication
- Unsaturated Ionizable Lipids and Nanoparticle Compositions Thereofapplication
- Enhanced Nuclear Delivery of DNA and Compositions for Use In Practicing the Sameapplication
- Enhanced Nuclear Delivery of DNA and Compositions for Use In Practicing the Sameapplication
- Ionizable Lipids And Lipid Nanoparticle Compositions For The Delivery Of Nucleic Acidsapplication
- Nucleic Acid Payload Delivery Systems, Compositions, And Methodsapplication
- Nuclear Targeted Dna Delivery And Compositions For Use In Practicing The Sameapplication
- Novel Lipid Nanoparticle Compositions For The Delivery Of Nucleic Acidsapplication
- Ionizable Lipids And Lipid Nanoparticle Compositions For The Delivery Of Nucleic Acidsapplication
- Nucleic Acid Payload Delivery Systems, Compositions, and Methodsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.